Placentation in equids involves two types of trophoblast: a minor invasive component, the chorionic girdle, that gives rise to transient endocrine structures known as endometrial cups, and a major non-invasive component, the allantochorion, that forms the diffuse, microcotyledonary placenta. Growth factors are likely to be important in controlling these complex events at implantation and this study describes the use of in situ hybridization and northern blotting techniques to monitor expression of insulin-like growth factor II (IGF-II) in the fetus and placenta of the horse (Equus caballus), using 12 conceptuses recovered between 14 and 150 days of gestation (term is about 340 days). The anti-sense, but not the sense, ovine IGF-II oligonucleotide probe (45 mer) hybridized to a total of seven IGF-II mRNA transcripts (6.2\p=n-\1.3kb) in RNA extracted from horse fetal liver, demonstrating the specificity and validity of the probe for equine IGF-II mRNA. In situ hybridization demonstrated that the IGF-II gene was expressed intensely in the fetus at all stages examined, predominantly in tissues of mesodermal origin, but also in the endoderm-derived liver and epithelia of the gut and lung bronchioles, and the ectoderm-derived facial mesenchyme and choroid plexus. High concentrations of IGF-II mRNA were also detected in the extraembryonic mesoderm, invasive chorionic girdle and mature endometrial cup tissue. There was no signal in the maternal endometrium at any stage of pregnancy. Higher concentrations of IGF-II message in the invasive chorionic girdle than the non-invasive trophoblast at the time of invasion suggests that IGF-II promotes invasiveness of trophoblast, as proposed in humans. Furthermore, increased concentrations in the allanto¬ chorion after implantation suggest a possible role in the development of the epitheliochorial placenta.
Introduction
The insulin-like growth factors (IGFs) I and II are single chain polypeptides of approximately 7.5 kDa that have mitogenic and differentiating effects on a diversity of somatic cell types. The actions of IGFs are mediated primarily through the type I IGF receptor (Humbel, 1990) and they are modulated by a complex series of binding proteins (Baxter and Martin, 1989) . IGF-II is expressed predominantly in the fetus and its role in the growth and differentiation of cells during mammalian embryogenesis has been reviewed in some detail (Hill and Hogg, 1989; Baker et al, 1993) . Beck et al. (1987) and Stylianopoulou et al. (1988) localized IGF-II mRNA transcripts in the developing rodent fetus, by in situ hybridization, to the liver, head mesenchyme, tissues of somitic and lateral mesoderm origin, skeletal muscle and developing cartilage, cardiac mesenchyme and yolk sac meso¬ derm. Derivatives of embryonic ectoderm, such as the periph¬ eral and central nervous systems, showed no expression, with the exception of the choroid plexus. Lee et al (1990) Received 19 September 1994. demonstrated transient expression of IGF-II transcripts in the primitive endoderm before yolk sac formation, with a sub¬ sequent shift in expression to the extraembryonic mesoderm at the primitive streak stage. The embryo itself did not express IGF-II mRNA until the late primitive streak/neural plate stage, when transcripts were localized specifically to the lateral mesoderm, the anterior-proximal cells that participate in the formation of the heart and foregut epithelium, the cranial mesenchyme and the pre-somitic somitic mesoderm. IGF-II expression has also been studied in the human conceptus, in which the first accumulation of IGF-II transcripts is detected between 5 and 18 days after fertilization in the Langhans' layer of trophoblastic villi and the trophoblast layer of the amniotic plate (Brice et al, 1989; Ohlsson et al, 1989) . Between 18 days and 14 weeks of gestation, IGF-II gene expression in the human fetus follows a similar tissue-specific pattern to that described in rodent embryogenesis (Brice et al, 1989 ). In addition to strong IGF-II mRNA expression in the fetal liver and tissues derived from embryonic mesoderm, expression was also intense in the adrenal cortex and metanephric blastema of the kidney, but declined as the level of differentiation in these tissues increased.
There is considerable evidence that inappropriate expression of IGF-II mRNA is a major factor in the aetiology of several childhood tumours, such as Wilm's tumour (embryonal nephroblastoma), hepatoblastoma and adrenal cortical carcinoma (Scott et al, 1985; Haselbacher et al, 1987) . The most direct evidence for a physiological role of IGF-II in embryonic growth comes from IGF-II gene targeting studies. De Chiara et al. (1990, 1991) disrupted one of the IGF-II alíeles in cultured mouse embryonic stem cells by mutation and then used the resulting cells to construct chimaeric animals. Transmission of the inactivated IGF-II alíele from male chimaeras resulted in heterozygous progeny 40% smaller than their wild-type littermates. In addition to demonstrating a role for IGF-II in fetal growth, this study showed that only the paternal IGF-II alíele is expressed in embryos. Ferguson-Smith et al (1991) also demonstrated preferential expression of the paternal IGF-II alíele in mice, confirming that this gene is maternally imprinted (paternally expressed). Barlow et al (1991) showed that the IGF-II receptor was paternally imprinted (maternally expressed) in mice.
Expression of IGF-II in placental tissues is well documented in rodents (Beck et al, 1987; Stylianopoulou et al, 1988; Lee et al, 1990) . After formation of the yolk sac in the early embryo, IGF-II mRNA is detected in the trophoblast, chorion, visceral yolk sac and allantois. In the later placenta (day 9.5-18.5), it is expressed in vasculogenic mesenchyme derived from the allantois, and in the trophoblast, where expression follows a dynamic pattern reflecting the continuing differen¬ tiation of this tissue (Redline et al, 1993) . Similar observations have been made in the human placenta by Ohlsson et al (1989) and Glaser et al. (1992) who found that IGF-II was expressed in the vasculogenic mesenchyme, the early cytotrophoblast shell and the later intermediate and villous trophoblast layers. Lysiak et al (1993) studied the effects of IGF-II on the proliferation and invasiveness of first trimester human trophoblast isolated from expiants of chorionic villi in vitro. They observed that the ability of the trophoblast to penetrate Matrigel-coated Millipore membranes in transwell invasion chambers increased in a dose-dependent fashion in the presence of increasing concentrations of IGF-II. Furthermore, they demonstrated a modulating effect of IGF-binding protein I (IGFBP-1) on trophoblast invasion in vitro, while Hill et al (1993) demon¬ strated, by immunohistochemistry, the presence of IGFBP-1 and -2 in the syncytiotrophoblast, intermediate trophoblast, amnion and decidual tissues.
A unique aspect of trophoblast growth and differentiation in horses involves the development, between days 25 and 35 after ovulation, of an annulate band of highly proliferative trophoblast cells called the chorionic girdle (Allen and Moor, 1972) . This hyperplastic region of the trophoblast invades the maternal endometrium between days 36 and 38 to form a series of discrete endometrial protuberances called endo¬ metrial cups (Allen et al, 1973) . Each cup is composed of a densely packed mass of large, binucleate epithelial-type cells of trophoblast origin which secrete chorionic gonadotrophin (eCG) into the maternal blood stream via a complex network of lymph sinuses that develop beneath each cup. The remain¬ ing trophoblast is non-invasive and, from day 40-42 onwards, develops an increasingly complex microvillous, microcotyledonary interdigitation with the maternal endometrium to form the true epitheliochorial placenta (Samuel el al, 1974 ).
In the present study, the techniques of in situ hybridiz¬ ation and northern blotting were used to investigate IGF-II expression in the horse conceptus and, in particular, the extraembryonic membranes, during chorionic girdle development and invasion of the endometrium and during establishment of the epitheliochorial placenta.
Materials and Methods

Tissues
Samples of extraembryonic membranes or placenta, the fetus, endometrial cups and biopsies of endometrium, with and without attached placenta, were recovered from 12 pregnant mares on days 14, 20, 30, 33, 35, 36, 38, 40, 46, 60, 78 and 150 after ovulation by two methods. The first, in mares before day 36, involved flushing the unattached, spherical conceptus from the uterus by lavage with 500-1000 ml sterile phosphatebuffered saline pH 7.2 (PBS), via a 14 mm diameter endotracheal tube passed through the cervix. This was followed by non-surgical endometrial biopsy, as described by Ricketts (1975) . The second method involved surgical hysterotomy via ventral midline laparotomy, which was performed under halothane-maintained general anaesthesia in the mares between days 36 and 150 of gestation. Control samples of endo¬ metrium, liver and kidney were recovered from two non¬ pregnant mares post-mortem. For in situ hybridization experiments, tissue samples were snap frozen immediately after removal from the mare and embedded in OCT compound (British Drug Houses, Poole) prior to cryosectioning. For northern blots, approximately 1 g samples of each tissue were wrapped in aluminium foil, frozen in liquid N2 and stored at -70°C until required for RNA extraction.
Probes
For both in situ hybridization and northern blot experiments, synthetic sense and antisense oligonucleotide probes (antisense: 5'-AAC TGG AGG GTG TCA CCA GCT CCC CGC CGC ACA GAG TCT CGC TGG-3') were based on a region in exon 4 of the ovine IGF-II gene sequence (O'Mahoney and Adams, 1989) . For in situ hybridizations, the probes were labelled with a35S-[dATP] (1200 Ci mmol"1, New England Nuclear, Stevenage) to a specific activity of > 109 d.p.m. µg~x using terminal deoxynucleotidyl transferase (Pharmacia, St Albans). For northern blots, they were labelled with a32P-[dCTP] (6000 Ci mmoP1, New England Nuclear) to a specific activity of 1010 d.p.m. ng^1.
In situ hybridization
Cryostat sections, 7-12 µ thick, were thaw-mounted onto poIy-L-lysine coated microscope slides, fixed by immersion in a solution of 4% (w:v) paraformaldehyde in PBS (pH 7.2) for had been treated with 0.1% (w:v) diethylpyrocarbonate (DEPC) and autoclaved to destroy ribonuclease enzymes. Hybridization was performed in a buffer consisting of 50% (v:v) deionized formamide, 10% (w:v) dextran sulphate, 0.3 mol NaCl 1 , 5 Denhardts reagent (Sambrook et al, 1989), 25 mmol sodium phosphate 1~( pH 6.8), 100 ng polyadenylic acid ml~, 0.5 mg salmon testes DNA ml~1 and 50 mmol dithiothreitol 1~. Each labelled probe was diluted in buffer to a concentration of 3 IO3 d.p.m. µ ~1, and 100 µ of this sol¬ ution was applied to each slide followed by incubation at 42°C for a minimum of 16 h. The slides were then washed in a solution of 1 SSC (150 mmol sodium chloride I , 15 mmol trisodium citrate 1~, pH 7.0) containing 0.1% (w:v) sodium thiosulphate, once for 45 min at room temperature and again for 45 min at 50°C. They were then rinsed for 5 min in 0.1 SSC and dehydrated sequentially in 50%, 70% and 95% (v:v) ethanol, before being air-dried. After initial X-ray film autoradiography, the sections were coated with a 1:2 dilution of Ilford K5 photoemulsion, air-dried and exposed for 2 weeks in a light-proof box containing silica gel. Finally, the slides were developed in phenisol developer (Ilford Ltd, Mobberley), fixed and stained with haematoxylin and Northern blot analysis Total RNA was isolated from 1 g samples of each tissue by the method of Chomczynski and Sacchi (1987) . Approximately 20 pg of total RNA from each tissue was then fractionated together with RNA molecular size markers (Gibco BRL, Paisley), on a 1% (w:v) agarose-formaldehyde gel and transferred to a nylon membrane (Hybond N; Amersham International, Amersham). The membrane was pre-hybridized for 2 h with approximately 8 ml of the in situ hybridization buffer described above. Labelled oligonucleotide probe was then added to the hybridization buffer at a concentration of 3 x 103 d.p.m. µ " 1 for hybridization at 42°C for 16 h. Filters were washed 3-4 times in 2 SSC, 0.1% (w:v) sodium dodecylsulphate (twice at room temperature and at least once at 45°C) before being exposed to X-ray film (X-OMAT; Kodak) at -70°C for between 16 h and 3 days.
Results
In situ hybridization
The antisense oligonucleotide probe demonstrated stable, highly localized hybridization patterns exclusively in tissues of fetal origin and the results are summarized in Figs 1-5. At no stage was hybridization of the antisense probe detected in the maternal endometrium. Furthermore, the sense control probe produced no specific hybridization to any tissue at any stage (Fig. 1 ).
In the fetus, expression of mRNA encoding IGF-II, as revealed by hybridization of the antisense probe, was detected in a diversity of cell types at all stages studied (Fig. 2 ). Early embryonic somites consisted of blocks of mesodermal cells lying along each side of the neural tube. By day 30 after ovulation, the processes of somitic differentiation were well established and high concentrations of mRNA encoding IGF-II were detected in the sclerotome-derived chondrocytes of the early spinal cord and head mesenchyme, and in the skin, tongue, liver and mesonephros ( Fig. 2a, b ). At day 35 ( Fig. 2c, d ) and 38 ( Fig. 2e, f ), the expression of mRNA IGF-II in the cartilage-forming cells of the developing skeleton had increased and was also evident in the myotome-derived striated muscle components. By day 46 (Fig. 2g, h) , fetal organogénesis was complete and expression of IGF-II tran¬ scripts in dermatome-and myotome-derived tissues, such as the skin and skeletal muscle, was still intense. However, in the ossifying chondrocytes of the peripheral skeleton, expression was declining by this stage. In situ hybridization analysis of insulin-like growth factor II (IGF-II) gene expression in the developing horse fetus, (a) Bright-field photomicrograph of a section of a day 30 horse fetus hybridized to the IGF-II antisense probe, exposed to photographic emulsion and stained with haematoxylin and eosin. (b) Dark-field photomicrograph of the same section illustrating the hybridization signal, (c) and (d) Bright-and dark-field photomicrographs, respectively of a section of a day 35 fetus hybridized to the IGF-II antisense probe, (e) and (f) Brightand dark-field photomicrographs of a section of a day 38 fetus hybridized to the IGF-II antisense probe, (g) and (h) Brightand dark-field photomicrographs of a section of a day 46 fetus hybridized to the IGF-II antisense probe. Note the strong hybridization signal, predominantly in tissues of mesodermal origin, but also in the endoderm-derived liver and ectoderm-derived skin and skeletal muscle. Note also the general lack of signal in the brain. At days 30 and 35 after ovulation, expression was intense in the mesonephros ( Fig. 2a-d ) and at days 38 and 46, high concentrations of IGF-II mRNA were detected in the presump¬ tive gonads and kidney ( Fig. 2e-h) . Lateral mesoderm deriva¬ tives, such as the pericardium, epimyocardium and endocardium of the heart, expressed IGF-II transcripts at all stages studied but the amount was reduced in the day 46 fetus (Fig. 2g, h) . The adrenal cortex, also a derivative of the lateral mesoderm expressed high levels of IGF-II mRNA (Fig. 2e, f) , as did the fetal kidney ( Fig. 2e-h) .
The distribution of IGF-II transcripts in ectodermal deriva¬ tives was not so widespread. They were not found in deriva¬ tives of the neural tube, with the exception of the choroid plexus ( Fig. 2e, f) , whereas head and facial mesenchyme, which contribute to the formation of the maxilla, palate, mandible, facial and orbital cartilage and tongue, were intensely labelled at all stages. In contrast, the neural crest-derived cranial sensory ganglia surrounding the myelencephalon, mesencephalon and telencephalon, failed to show expression at any stage. In the section of the day 35 fetus (Fig. 2c,d) , the fetal pituitary gland was evident and demonstrated high IGF-II gene expression.
In tissues of endodermal origin, IGF-II gene expression was similarly confined to specific tissue types, such as the liver, where at all stages studied, the expression was very high. Furthermore, expression of mRNA encoding IGF-II in the fetal liver was diffuse and not confined to one particular cell type. A much lower expression was exhibited by the epithelial cells of the trachea, lung bronchioles and gastrointestinal tract ( Fig. 2c-h) . The in situ hybridization results on the extraembryonic membranes are summarized in Figs 3-5. In the pre-implantation conceptuses, no IGF-II gene expression was detected in the early yolk sac endoderm or outer trophoblast layers at day 14 ( Fig. 3a, b ) but from day 20, expression was intense in the vascularized mesoderm developing between the inner endo¬ derm and outer trophoblast cell layers (Fig. 3c, d ) and at day 36, in the cells of the developing chorionic girdle (Fig. 3e, f) . At this stage, the non-invasive trophoblast of the allantochorion exhibited no hybridization, illustrating a marked difference between the invasive (chorionic girdle) and non-invasive com¬ ponents of trophoblast. After invasion of the chorionic girdle into the endometrium at day 36-38, the resulting binucleate endometrial cup cells continued to express high amounts of mRNA encoding IGF-II (Fig. 4) . The day 46 endometrial cup (Fig. 4a, b ) consisted of large, healthy IGF-II-positive binucleate cup cells surrounded by maternal lymphocytes. The adjacent normal allantochorion, not present in this section, was already becoming attached to the endometrial epithelium at this stage (see Fig. 5a , b). Figure 4g and h illustrate the day 46 endometrial cup at a higher magnification, to show several IGF-II-negative maternal endometrial glands surrounded by IGF-II-positive fetal cup cells. In the day 60 specimen, the allantochorion was firmly attached to the endometrium and was strongly positive and the large fetal endometrial cup cells were also positive. However, by day 80 (Fig. 4e,f) , the endometrial cup region had become negative owing to degeneration and necrosis of the fetal cup cells and the commencement of sloughing of the necrotic cup from the surface of the endometrium. Examination of placental development away from the endometrial cups showed that both the non-invasive tropho¬ blast and the underlying mesenchymal tissue demonstrated a marked upregulation of IGF-II gene expression during forma¬ tion and interdigitation of the chorioallantoic placenta (Fig. 5 ).
From the earliest interdigitation between the allantochorion and luminal epithelium of the endometrium at day 46 (Fig. 5a, b ) to the development of the complex microcotyledonary placenta at day 150 (Fig. 5g, h) , the amount of mRNA encoding IGF-II in the placental membranes remained high.
At no stage was any IGF-II gene expression exhibited by any component of the maternal endometrium, and IGF-II expression, therefore, provided an accurate marker of fetal tissue within the developing horse placenta.
Northern blots
The northern blot analyses of total RNA extracted from fetal and maternal tissues is illustrated in Fig. 6 . The antisense oligonucleotide probe hybridized to multiple transcripts in all fetal tissues but was negative in adult tissues (for example, the endometrium; lane 2) except for the kidney, in which two transcripts were evident (lane 1). The most intense gene expression was demonstrated by fetal liver on day 78 (lane 4) where a total of 7 transcripts (6.2 kb, 4.0 kb, 3.5 kb, 2.8 kb, 2.05 kb, 1.4 kb and 1.3 kb) were detected. Expression was lower in other fetal tissues (for example, muscle; lane 3). These results were consistent with studies in other species and confirmed the specificity of the ovine IGF-II oligonucleotide probe for equine IGF-II mRNA.
Discussion
Our demonstration of seven IGF-II transcripts in horse fetal RNA concurs with similar findings in sheep fetuses, in which ten major transcripts of 6.2-1.3 kb were identified (O'Mahoney et al, 1992) , in the rat fetus where four transcripts of 6.0-1.2 kb were detected (Brown el al, 1986) and in human fetal tissues in which five transcripts of 6.0-1.8 kb were identified (LeBouc el al, 1987). Expression of IGF-II as a multitranscript family suggests a complex pattern of transcriptional control of this growth factor, which may have functional significance during development (Brown el al, 1986) .
The in situ hybridization results in the horse fetus agree with studies on IGF-II gene expression during rodent and human embryogenesis (Beck et al, 1987; Stylianopoulou et al, 1988; Brice et al, 1989 ) and suggest that, as in other species, IGF-II acts as an autocrine or paracrine mitogen for a variety of tissues during embryogenesis. The greatly reduced body size of mice carrying a paternally inherited mutated alíele of the IGF-II gene (DeChiara el al, 1991) and the increased growth of fetal mice with a duplication of the paternal IGF-II alíele (Fergusson-Smith el al, 1991) also support a mitogenic role for IGF-II in embryogenesis and placental growth and development.
IGF-II was expressed in the extraembryonic membranes of the horse conceptus in a developmentally regulated manner and showed a clear correlation with the unusual events of Fig. 3 . Bright-and dark-field photomicrographs illustrating the in situ hybridization analysis of insulin-like growth factor II (IGF-II) gene expression in the extraembryonic membranes of the horse conceptus. There is no positive hybridization in the endoderm (E) or trophoblast (T) layers at day 14 after ovulation (a, b). At day 20, a high level of IGF-II expression is evident in the vascularized mesoderm (M) developing between the endoderm and outer trophoblast layers (c, d) . By day 36 (e, f), IGF-II gene expression is localized to the mesoderm of the allantochorion (A), to the proliferating invasive trophoblast cells of the chorionic girdle (CG) and to the underlying mesothelium (MT). Note the absence of expression in the trophoblast layer of the non-invasive allantochorion (A). Scale bars represent 20 µ . placentation in this species. The strong expression observed in the chorionic girdle before its invasion of the endometrium is comparable to the high IGF-II expression in human inter¬ mediate trophoblast and murine glycogen cells and may be analogous to the IGF-II autocrine stimulatory loop thought to be fundamental to the development of the invasive human placenta (Ohlssen el al, 1989; Glaser et al, 1992; Redline et al, 1993) . Likewise, the intense expression of IGF-II in the vascularized allantois of the allantochorion from day 20 onwards appears analogous to that observed in the vasculogenic mes¬ enchyme and villous stroma of human and mouse conceptuses. Furthermore, expression in non-invasive trophoblast cells from day 46 onwards correlates with expression of IGF-II in the cytotrophoblast layer of human villous trophoblast, and in the three-layered labyrinthine trophoblast of mice.
In equids, development of the chorionic girdle between days 25 and 35 after ovulation involves a rapid and unusual multiplication of trophoblast cells to form long finger-like processes of hyperplastic cells. This development is very discrete and is strictly limited to the area of trophoblast that overlies the point of abutment of the developing allantois and the regressing yolk sac (van Niekerk and Allen, 1975) . In this region, the trophoblast has no adjacent vascular meso¬ derm but, instead, has an underlying compartment bordered on one side by the yolk sac mesoderm and on the other by the allantoic mesoderm (Enders and Liu, 1991) . Hence, the marked upregulation of IGF-II gene expression observed in the trophoblast cells of the chorionic girdle may be related to the absence of underlying mesoderm in this area. It is possible that the vascular mesoderm produces a factor Fig. 4 . Brightand dark-field photomicrographs illustrating the in situ hybridization analysis of insulin-like growth factor II (IGF-II) gene expression in the endometrial cups and surrounding maternal endometrium at days 46 (a, b, g, h), 60 (c, d) and 80 (e, f) after ovulation. A high concentration of mRNA encoding IGF-II is present in endometrial cup cells (EC) at days 46 and 60 but, by day 80, the level of expression had declined due to necrosis of the cup cells. Expression is also strong in the allantochorion (A) at day 60 and day 80, but absent in the maternal endometrium. (g) and (h) are higher power photomicrographs of the day 46 endometrial cup showing expression of IGF-II in the fetal cup cells but no expression in the maternal endometrial glands. G: endometrial glands; GE: glandular epithelium; LE: luminal epithelium; L: lymphocytes. Scale bars represent 2 mm (a-f) and 20 µ (g, h). capable of inhibiting this type of trophoblast proliferation, operating over the majority of the conceptus, which is unable to reach and affect the area upon which the chorionic girdle develops. The result of this is that the trophoblast in this area can respond to a stimulus of maternal or fetal origin, leading to upregulation of IGF-II gene expression Fig. 5 . Bright-and dark-field photomicrographs illustrating the in situ hybridization analysis of insulin-like growth factor II (IGF-II) gene expression in the non-invasive placenta at day 46 (a, b), day 60 (c, d), day 80 (e, f) and day 150 (g, h) after ovulation. At all stages of development, from the commencement of interdigitation with the maternal endometrium at day 46 to the establishment of the branched microvilli (MV) of the mature microcotyledon at day 150, both the trophoblast and allantoic mesenchyme layers of the allantochorion (A) express high levels of IGF-II mRNA. No IGF-II gene expression is evident in the luminal epithelium (LE), glandular epithelium (GE) or endometrial stroma. Scale bars represent 20 µ . and a switch to invasiveness. Since it is possible to grow horse chorionic girdle cells in tissue culture (Allen and Moor, 1972) Growth regulation in early mammalian conceptuses may involve parental gene imprinting that results in selective, differential expression of growth factor genes. Furthermore, in the case of IGF-II, reciprocal imprinting occurs, where the paternal alíele of the growth factor and the maternal alíele of its receptor are expressed (Di Chiara et al, 1991; Barlow et al, 1991) . Paradoxically, the mitogenic actions of IGF-II appear not to function through its own high-affinity receptor, but through the type IIGF receptor, at least in the embryo. However, Baker et al (1993) propose that a third, unknown IGF receptor may be responsible for IGF-II stimulation of placental growth.
In horse placentation, the width and overall development of the progenitor chorionic girdle, and hence the size and se¬ cretory activity of the resulting endometrial cups, appear to be determined by paternal genotype. Studies in mares and Jenny donkeys carrying intraspecies horse and donkey pregnancies, or interspecies mule and hinny pregnancies, revealed that when the sire is a horse (horse and hinny conceptuses), a broad, thick chorionic girdle develops on the conceptus, giving rise to large, active endometrial cups. However, when the sire is a donkey (donkey and mule conceptuses), the girdle and resulting endometrial cups are significantly smaller (Allen, 1975; Stewart and Allen, 1981 ). This marked effect of paternal genotype is strongly influenced by uterine environment, as was demon¬ strated by using embryo transfer to create extraspecies horse pregnancies. Transfer of a horse embryo to the uterus of a Jenny donkey results in a broad girdle and large, active endometrial cups, whereas transfer of a donkey embryo to a horse recipient produces an exceptionally narrow girdle that fails completely to invade the maternal endometrium to form cups (Allen, 1982; Allen et al, 1987) . Transfer of an interspecies mule embryo, which would normally produce a narrow chori¬ onic girdle, into the uterus of a Jenny donkey results in the development of a very large and active chorionic girdle, giving rise to endometrial cups typical of those seen in a donkey carrying an interspecies hinny conceptus (Allen et al, 1993) . To explain this apparent conflict between paternal genotype and uterine environment, we proposed reciprocal genomic imprint¬ ing of a growth factor and its receptor interacting with a negative uterine factor that is greater in the horse than in the donkey (Allen et al, 1993) . Our findings in this study offer the possibility that the reciprocally imprinted growth factor and receptor might be, respectively, IGF-II and the placentalspecific IGF-II receptor proposed by Baker et al (1993) , with one of the IGF-binding proteins constituting the inhibitory uterine factor. The ability to create hybrid pregnancies in equids facilitates studies on specific gene imprinting and experiments are underway to determine whether the equine IGF-II gene is imprinted.
In conclusion, IGF-II is widely expressed in equine fetal tissues, and probably stimulates a wide diversity of cell types during development. In addition, it is possibly influenced by genomic imprinting and may be intrinsic to the development of both the invasive chorionic girdle and the non-invasive trophoblast that lines the outer surface of the definitive allantochorionic placenta in mares.
